• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More

    6/23/22 12:29:36 PM ET
    $ADN
    $AERC
    $ANEB
    $APLT
    Industrial Machinery/Components
    Miscellaneous
    Environmental Services
    Utilities
    Get the next $ADN alert in real time by email

     

    Gainers

    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
    • F-star Therapeutics, Inc. (NASDAQ:FSTX) shares jumped 58% to $6.28 after Sino Biopharmaceutical's invoX Pharma announced it will acquire the company for $7.12 per share. The acquisition values F-star at approximately $161 million.
    • Shift Technologies, Inc. (NASDAQ:SFT) gained 44% to $1.0200.
    • Smart for Life, Inc. (NASDAQ:SMFL) jumped 42% to $0.63. Smart for Life's Doctors Scientific Organica division has accelerated production of Milk Dust to increase milk supply, nourish the postpartum body, and help combat sugar cravings.
    • Phoenix Motor Inc. (NASDAQ:PEV) gained 37.4% to $8.01. Phoenix Motor recently reported closing of $15,750,000 initial public offering.
    • Vroom, Inc. (NASDAQ:VRM) gained 25.4% to $1.4850.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) surged 25.3% to $4.26.
    • Valneva SE (NASDAQ:VALN) shares jumped 25% to $31.07. Valneva received positive CHMP opinion for marketing authorization of its inactivated Covid-19 vaccine candidate in Europe.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) surged 23.7% to $1.0891.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) jumped 22.8% to $3.18. JonesTrading initiated coverage on Rain Therapeutics with a Buy rating and announced a price target of $17.
    • MSP Recovery, Inc. (NASDAQ:MSPR) gained 20% to $2.2673.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) surged 19.1% to $0.30. The FDA recently granted Fast Track Designation to the company’s VAL-083.
    • CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) gained 17.8% to $0.3301 after the company received FDA approval for a protocol amendment to its ongoing study evaluating Berubicin in recurrent glioblastoma multiforme.
    • ATIF Holdings Limited (NASDAQ:ATIF) jumped 17.7% to $2.32.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 17.4% to $0.8995 after the company reported its Q1 earnings results.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) rose 16% to $0.3085. NextPlay Technologies recently reported FY22 revenue of $8.2 million.
    • Heliogen, Inc. (NYSE:HLGN) gained 15.9% to $3.64.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 15.8% to $1.5991. ToughBuilt Industries reported the closing of $6 million public offering.
    • Nutriband Inc. (NASDAQ:NTRB) jumped 15.6% to $3.25.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) gained 14.3% to $1.1314. Jiuzi will announce entry into an electric vehicle purchase agreement with authorized agent of WM Motor Technology Co., Ltd.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) surged 13.8% to $1.24.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) rose 13.7% to $0.29 after gaining more than 5% on Wednesday.
    • ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) gained 13.6% to $0.52.
    • Motorsport Games Inc. (NASDAQ:MSGM) surged 12.8% to $0.6397.
    • ChromaDex Corporation (NASDAQ:CDXC) jumped 11.3% to $2.16.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) rose 8.4% to $1.42. GeoVax Labs recently announced the appointment of John W. Sharkey, PhD to serve as Vice President, Business Development.

     

     

    Losers

    • BIT Mining Limited (NASDAQ:BTCM) shares dipped 40.4% to $0.7089 after the company announced a $16 million registered direct offering.
    • Applied Therapeutics, Inc. (NASDAQ:APLT) fell 25.4% to $0.7981 as the company reported pricing of $30 million public offering of common stock and warrants.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) shares tumbled 19.7% to $6.16. Grove Collaborative Holdings’ 10% owner Richard Sir Branson recently acquired a total of 19,394,024 shares at an average price of $10.00.
    • IperionX Limited (NASDAQ:IPX) fell 18.2% to $6.46.
    • Revlon, Inc. (NYSE:REV) fell 17% to $6.76 on continued volatility following the company's recent bankruptcy filing.
    • Actelis Networks, Inc. (NASDAQ:ASNS) dropped 15.3% to $1.60. Actelis Networks recently posted a Q1 loss of $2.26 per share.
    • JX Luxventure Limited (NASDAQ:LLL) fell 14.4% to $1.49. JX Luxventure shares jumped around 17% on Wednesday after the company announced a $5 million share repurchase program and signed a $30 million sales agreement.
    • bluebird bio, Inc. (NASDAQ:BLUE) declined 13.2% to $3.87.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) fell 12.2% to $13.00.
    • cbdMD, Inc. (NYSE:YCBD) dropped 11.7% to $0.4560.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) fell 10.6% to $1.0900. Rigel Pharmaceuticals recently announced data from the FORWARD Phase 3 clinical trial of Fostamatinib did not demonstrate statistical significance in the primary efficacy endpoint.
    • National CineMedia, Inc. (NASDAQ:NCMI) dipped 10.5% to $0.9298.
    • Century Aluminum Company (NASDAQ:CENX) fell 10.1% to $7.68. BMO Capital maintained Century Aluminum with a Market Perform and lowered the price target from $14 to $9.
    • Deutsche Bank Aktiengesellschaft (NYSE:DB) declined 10.1% to $9.19.
    • Exela Technologies, Inc. (NASDAQ:XELA) dropped 9.9% to $0.1710. Exela Technologies recently announced a new customer win of $136 million in total contract value
    • Advent Technologies Holdings, Inc. (NASDAQ:ADN) dipped 9.6% to $2.93.
    • Green Giant Inc. (NASDAQ:GGE) fell 8.6% to $1.2892.
    • U.S. Well Services, Inc. (NASDAQ:USWS) dropped 8.3% to $0.9020. ProFrac announced it will acquire the company for approximately $1.21 per share in an all-stock deal.

     

    Get the next $ADN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADN
    $AERC
    $ANEB
    $APLT

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Applied Therapeutics Inc.
    $APLT
    12/12/2025Outperform → Neutral
    Robert W. Baird
    Applied Therapeutics Inc.
    $APLT
    12/3/2025$1.00Outperform → Market Perform
    Leerink Partners
    Rigel Pharmaceuticals Inc.
    $RIGL
    11/5/2025$42.00Hold → Buy
    Jefferies
    National CineMedia Inc.
    $NCMI
    10/31/2025$7.00 → $6.50Outperform
    Barrington Research
    Century Aluminum Company
    $CENX
    10/8/2025Overweight
    Wells Fargo
    Deutsche Bank AG
    $DB
    8/27/2025Buy → Neutral
    Goldman
    Valneva SE
    $VALN
    8/19/2025$18.00Buy
    H.C. Wainwright
    More analyst ratings

    $ADN
    $AERC
    $ANEB
    $APLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Century Aluminum Applauds President Trump for Executive Order to Fully Enforce Sec. 232 Aluminum Tariffs

    CHICAGO, April 02, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) is applauding President Donald Trump's new executive order that will close valuation loopholes that importers have been using to avoid the President's tariffs on steel and aluminum, leveling the playing field for American manufacturers. The Section 232 tariff on primary aluminum is unchanged and remains at 50 percent. Importers had been abusing valuation loopholes to reduce their liability under the President's steel and aluminum tariffs. In some instances, importers declared only the value of raw steel and aluminum while excluding value added through processing, thereby lowering the tariff owed and disadva

    4/2/26 3:52:23 PM ET
    $CENX
    Aluminum
    Industrials

    cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

    Company brings one of the only combined clinical and toxicological safety dataset in the hemp-derived CBD category into a new provider channel as CMS activates cannabinoid access within value-based care modelsCHARLOTTE, N.C., April 1, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leader in science-driven cannabinoid products, today announced the launch of its clinical healthcare channel, positioning the Company to support physicians, health systems, and value-based care organizations as federal policy establishes structured pathways for hemp-derived cannabinoid products within Medicare programs.

    4/1/26 8:30:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Le Mans Ultimate Releases Version 1.3 Update, Introducing Circuit de Barcelona-Catalunya, Duqueine D09 LMP3 Race Car, New Track Layouts, Logitech Trueforce Support and Performance Improvements

    MIRAMAR, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ:MSGM) ("Motorsport Games" or the "Company"), a racing game developer, publisher, and esports ecosystem provider of official motorsport racing series, today released version 1.3 of Le Mans Ultimate, delivering the final European Le Mans Series Season Pass content pack, significant new track layouts, native Logitech Trueforce and haptic feedback integration, substantial performance optimizations, and continued improvements to online competition systems. Version 1.3 completes the European Le Mans Series ("ELMS") Season Pass with the addition of the Duqueine D09, a third-generation LMP3 chassis powered by a twin-t

    3/31/26 9:00:00 AM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $ADN
    $AERC
    $ANEB
    $APLT
    SEC Filings

    View All

    SEC Form DEFA14A filed by Rigel Pharmaceuticals Inc.

    DEFA14A - RIGEL PHARMACEUTICALS INC (0001034842) (Filer)

    4/3/26 4:02:41 PM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Rigel Pharmaceuticals Inc.

    DEF 14A - RIGEL PHARMACEUTICALS INC (0001034842) (Filer)

    4/3/26 4:01:59 PM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Motorsport Games Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Motorsport Games Inc. (0001821175) (Filer)

    4/2/26 4:15:32 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $ADN
    $AERC
    $ANEB
    $APLT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Delta John bought $13,020 worth of shares (5,000 units at $2.60), increasing direct ownership by 71% to 12,000 units (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    12/12/25 5:31:22 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    Large owner Giustra Frank bought $734,725 worth of shares (178,205 units at $4.12) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    9/15/25 8:19:20 PM ET
    $BSGM
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Delta John bought $20,426 worth of shares (7,000 units at $2.92) (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    8/21/25 4:05:22 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $ADN
    $AERC
    $ANEB
    $APLT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADN
    $AERC
    $ANEB
    $APLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Woods Maria Vg

    4 - National CineMedia, Inc. (0001377630) (Issuer)

    4/2/26 4:52:52 PM ET
    $NCMI
    Advertising
    Consumer Discretionary

    SEC Form 4 filed by Ng Ronnie Y.

    4 - National CineMedia, Inc. (0001377630) (Issuer)

    4/2/26 4:47:58 PM ET
    $NCMI
    Advertising
    Consumer Discretionary

    SEC Form 4 filed by Lesinski Thomas F.

    4 - National CineMedia, Inc. (0001377630) (Issuer)

    4/2/26 4:39:58 PM ET
    $NCMI
    Advertising
    Consumer Discretionary

    $ADN
    $AERC
    $ANEB
    $APLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Applied Therapeutics downgraded by Robert W. Baird

    Robert W. Baird downgraded Applied Therapeutics from Outperform to Neutral

    12/12/25 9:22:39 AM ET
    $APLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Applied Therapeutics downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded Applied Therapeutics from Outperform to Market Perform and set a new price target of $1.00

    12/3/25 8:27:30 AM ET
    $APLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADN
    $AERC
    $ANEB
    $APLT
    Leadership Updates

    Live Leadership Updates

    View All

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Applied Therapeutics Reports Third Quarter 2025 Financial Results

    –   Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes –   Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat for the treatment of Classic Galactosemia –   New data on govorestat for the treatment of PMM2-CDG published in JIMD and presented at the 2025 ASHG Annual Meeting –   Announces Board of Directors Leadership Transition NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ:APLT) (the "Company"), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today reported financial results for the third quarter ended September 30

    11/13/25 7:00:00 AM ET
    $APLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Advent Technologies Commissions Arxicon as Master Planner for RHyno Project

    LIVERMORE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), through its wholly owned subsidiary Advent Technologies S.A., is pleased to announce its official collaboration with Arxicon, a leading Greek engineering and project management firm, for the development of its master plan for the RHyno Project. The RHyno Project officially commenced on April 1, 2025, and is funded by the EU Innovation Fund. It involves the development and construction of the facility and key infrastructure for manufacturing innovative fuel cells, electrolysers, and their critical components, including Advent's cutting-edge Membrane Electrode Assembly (MEA) technology, at

    10/27/25 8:45:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    $AERC
    $ANEB
    $APLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    SEC Form SC 13D filed by Exela Technologies Inc.

    SC 13D - Exela Technologies, Inc. (0001620179) (Subject)

    11/27/24 5:57:16 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    SEC Form SC 13D filed by Exela Technologies Inc.

    SC 13D - Exela Technologies, Inc. (0001620179) (Subject)

    11/27/24 4:00:55 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    $ADN
    $AERC
    $ANEB
    $APLT
    Financials

    Live finance-specific insights

    View All

    Le Mans Ultimate Releases Version 1.3 Update, Introducing Circuit de Barcelona-Catalunya, Duqueine D09 LMP3 Race Car, New Track Layouts, Logitech Trueforce Support and Performance Improvements

    MIRAMAR, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ:MSGM) ("Motorsport Games" or the "Company"), a racing game developer, publisher, and esports ecosystem provider of official motorsport racing series, today released version 1.3 of Le Mans Ultimate, delivering the final European Le Mans Series Season Pass content pack, significant new track layouts, native Logitech Trueforce and haptic feedback integration, substantial performance optimizations, and continued improvements to online competition systems. Version 1.3 completes the European Le Mans Series ("ELMS") Season Pass with the addition of the Duqueine D09, a third-generation LMP3 chassis powered by a twin-t

    3/31/26 9:00:00 AM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    Valneva Reports Full Year 2025 Audited Consolidated Financial Results

    Total revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 million, with enhanced financial flexibility following successful debt refinancing and a 21% reduction in operating cash burn2026 to be a potentially transformational year with Phase 3 Lyme disease data expected in the first half of the year Lyon (France), March 18, 2026 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today reported its audited consolidated financial results for the year ended December 31, 2025, provided corporate updates and confirmed its financial guidance for 20261. The Company also announced the filing of its annua

    3/18/26 2:00:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Motorsport Games Reports Fourth Quarter & Full Year 2025 Financial Results

    MIRAMAR, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ:MSGM) ("Motorsport Games" or "the Company") today reported financial results for its fourth quarter and fiscal year ended December 31, 2025. The Company has also posted the fourth quarter and fiscal year-end 2025 earnings slides highlighting key milestones that occurred during and subsequent to the period, which are accessible on the Company's investor relations website. "2025 was a breakthrough year for Motorsport Games," commented Stephen Hood, President and Chief Executive Officer. "Over the past two years we have reshaped the company around a clear strategy: focus on a smaller, disciplined team, build on t

    3/10/26 4:10:00 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology